Les innovations dans la prise en charge chirurgicale de l’aisselle.
Seance of wednesday 08 november 2023 (Sénologie)
DOI number : 10.26299/82bp-xh28/emem.2023.31.03
Abstract
Axillary lymph nodes dissection (ALND) in breast surgery represents a significant and innovative approach that has transformed the management of breast cancer patients. Traditionally, breast surgery involved radical procedures that often resulted in significant morbidity for patients, particularly due to the removal of axillary lymph nodes. However, with advancements in surgical techniques and an increasing understanding of breast cancer biology, there has been a shift towards more conservative and personalized approaches.
In term of ALND, our team described an innovative approach called G-INVERTED to ensure safety of procedure, adequate exposure and enhancing surgical training in the area of less invasive surgery.
One remarkable innovation is sentinel lymph node biopsy (SLNB), a technique that identifies and removes the first lymph node(s) to which cancer cells are most likely to spread. SLNB has revolutionized the field by allowing for accurate staging of breast cancer without the need for complete axillary dissection. This not only minimizes post-operative complications such as lymphedema but also improves the overall quality of life for patients.
Furthermore, advancements in minimally invasive techniques, including targeted axillary lymph nodes dissection and intraoperative imaging, have made axillary dissection more precise and less invasive. These innovations reduce the physical and emotional burden on patients and enhance their recovery.
In the era of personalized medicine, surgical innovation in axillary dissection is a critical component of breast cancer care. It not only ensures the effective treatment of the disease but also emphasizes the importance of preserving the patient's overall well-being.
In term of ALND, our team described an innovative approach called G-INVERTED to ensure safety of procedure, adequate exposure and enhancing surgical training in the area of less invasive surgery.
One remarkable innovation is sentinel lymph node biopsy (SLNB), a technique that identifies and removes the first lymph node(s) to which cancer cells are most likely to spread. SLNB has revolutionized the field by allowing for accurate staging of breast cancer without the need for complete axillary dissection. This not only minimizes post-operative complications such as lymphedema but also improves the overall quality of life for patients.
Furthermore, advancements in minimally invasive techniques, including targeted axillary lymph nodes dissection and intraoperative imaging, have made axillary dissection more precise and less invasive. These innovations reduce the physical and emotional burden on patients and enhance their recovery.
In the era of personalized medicine, surgical innovation in axillary dissection is a critical component of breast cancer care. It not only ensures the effective treatment of the disease but also emphasizes the importance of preserving the patient's overall well-being.